NCT05659537View on ClinicalTrials.gov

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

PHASE4CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

December 29, 2022

Primary Completion Date

January 16, 2024

Study Completion Date

January 16, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Dulaglutide

Administered SC

Trial Locations (7)

50034

Virinchi Hospital, Hyderabad

380015

Medlink Hospital Opp Someshwara Jain Temple, Ahmedabad

411001

Grant Medical Foundation - Ruby Hall Clinic, Pune

411004

Akshay Hospital, Pune

411057

Lifepoint Multispecialty Hsptl, Wakad

560092

Life Care Hospital and Research Centre, Bangalore

641009

Kovai Diabetes Speciality Center and Hospital, Coimbatore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY